Leukocyte Adhesion Deficiency clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I)

    Sorry, accepting new patients by invitation only

    This Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I) is a continuation of a Phase 1/2 clinical study to evaluate the safety and efficacy of the infusion of autologous hematopoietic stem cells transduced with a lentiviral vector encoding the ITGB2 gene

    Los Angeles, California and other locations

Our lead scientists for Leukocyte Adhesion Deficiency research studies include .

Last updated: